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Clusterin expression and apoptosis in tissue remodeling associated
with renal regeneration. To analyze the role of clusterin in renal diseases
involving a regenerative process, we have used a novel rodent model to
compare temporal and spatial expression of clusterin mRNA. Thus, renal
artery stenosis was used to induce unilateral non-infarctive renal atrophy.
After several weeks, when cellular pathology of atrophic kidneys involved
minimal apoptosis or inflammatory response and mitosis was at normal
levels, regeneration of atrophic kidneys was stimulated by removal of the
contralateral healthy kidneys. The regrowth response was very rapid and
involved renal hyperplasia rather than hypertrophy. Regenerating kidneys
were studied 0, 4, 8, 24 hours and 2, 3, 5, 7, and 14 days after contralateral
nephreetomy. Several parameters were compared; level and localization of
clusterin mRNA; cell proliferation; cell dedifferentiation and redifferen-
tiation; and apoptosis. During the acute regenerative phase (first 24 hr)
elusterin expression was markedly increased, decreasing to untraceable
levels by five days of regeneration. Clusterin mRNA was localized in
dilated or collapsed atrophic tubules that had lost identifying surface
structures of normal tubular epithelium (termed dedifferentiated). Clus-
term was also localized in the periphery of some blood vessel walls. Cell
proliferation peaked at three to five days of regeneration, and was also
localized in dedifferentiated tubules. Despite the regenerative stimulus, an
unexpected result was a transient but marked increase in apoptotic cell
death in atrophic tubules in the first 24 hours of regeneration. Our results
provide evidence of a temporal association between increased clusterin
expression and apoptosis, but in situ localization showed clusterin mRNA
over apparently viable, as well as apoptotic, cells in the epithelium of
tubules showing clusterin expression. Clusterin mRNA was rarely identi-
fied over epithelial cells in foci of non-atrophic (non-dedifferentiated)
nephrons that responded to the regenerative stimulus by cellular hyper-
trophy. The dramatic response after initiation of regeneration, especially
the initiation of apoptosis in the tubular epithelium, may have applications
for the study of genetic changes leading to renal oncogenesis.
A growing body of literature has recorded the clusterin gene
and its protein in several diverse renal diseases both in experi-
mental models [1—101 and human disease [11—16], as well as in
other non-renal tissues [17—23]. The gene and its protein are
known by several other names, including testosterone-repressed
prostate message (TRPM-2), sulfated glycoprotein-2 (SGP-2),
glycoprotein-80 (gp80), dimeric acidic glycoprotein (DAG), se-
rum protein-40,40 (SP-40,40), apolipoprotein J, and complement
lysis inhibitor (CLI) [24—30]. Although the exact physiological or
pathological role of clusterin remains undefined, various reports
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of its presence indicate a multifunctional involvement in renal
pathology that includes apoptosis (programmed cell death), cell
survival, promotion of cell-cell interactions, modulation of com-
plement system, tissue regeneration and remodeling, and renal
oncogenesis.
There is current debate as to the intrinsic involvement of
clusterin in the apoptotic process. Several publications show lack
of correlation between cell death and clusterin expression [31, 32],
and in the summary report of a recent symposium on clusterin
[28], general agreement appears to have been reached regarding
a lack of involvement of clusterin in the apoptotic mechanism.
Nonetheless, in several models of inducible tissue damage, high
levels of clusterin mRNA and protein correlate well with onset or
occurrence of apoptosis. Recurrent examples of such an associa-
tion in renal pathology are after ureteric obstruction [1—3, 8] and
ischemic or reperfusion injury [6, 9]. In one example, that of
ureteric obstruction, the gene is expressed prior to, and concur-
rent with, morphologically visible apoptosis, and is found only in
the atrophying kidney. It is not found in the contralateral healthy
organ, which is undergoing a compensatory growth that involves
cell hypertrophy with little hyperplasia [33—35]. Clusterin is ex-
pressed after a gene cascade (c-fos, c-myc, HSP7O) that is also
found in the contralateral kidney as part of the regenerative
response [2, 35]. In another example, involving reperfusion injury
after brief times of ischemic hypoxia [9], analysis of the exact role
of clusterin in response to reperfusion injury is made difficult by
multifactorial responses that include apoptosis, mitosis, as well as
acute tubular necrosis and the inflammatory infiltrate that is
inseparable from such necrotic damage.
In another report involving renal injury after brief total isch-
emia [5], increased clusterin expression was also recorded, but
these authors related the increased expression to the regenerative
response in tubular epithelial cells that occurred after ischemia-
induced tubular necrosis. Intrarenal localization of clusterin was
not studied, but in a subsequent paper that involved some of the
same authors [6], unilateral nephrectomy plus partial infarction of
the remnant kidney were used to induce renal cell proliferation, and
clusterin expression was found to be localized on the borders of the
infarcts. The authors also identified apoptosis in this zone. Defining
a role for clusterin was again hindered by the presence of a massive
immune response that also exists at the border of the infarcts.
There have been several publications suggesting that expression
of clusterin is related more to cell survival than to apoptosis in
regressing tissues [16, 21, 32]. Tissue remodeling is also referred
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to as one of the functions of clusterin [6, 151, but this term could
conceivably include cell deletion, proliferation, hypertrophy, dif-
ferentiation as well as structural changes. Such remodeling would
be expected, for example, in cystic tubular epithelium of polycystic
kidneys, where clusterin is expressed at increased levels [4, 15]. In
the present study, we have used a model of renal regrowth after
injury [361 to attempt to further define a role for clusterin in renal
pathology. In this model, unilateral non-infarcted atrophic kidneys
were stimulated to regenerate by removal of the contralateral healthy
kidneys. At the time of stimulus to regenerate, the pathology in the
atrophic kidneys comprised focal tubular atrophy, an expanded
interstitium with some fibrosis, and focal areas of hypertrophied, but
otherwise normal, tubules. The epithelium of atrophic tubules was
"dedifferentiated", being squamous or collapsed, with loss of brush
borders and other distinctive surface structures, and loss of lateral
contact between some adjoining epithelial cells. There was little
apoptosis, which had played a major pathogenic role in the earlier
development of renal atrophy, and no inflammatory responses such
as would be found with tubular necrosis. Unilateral nephrectomy of
the healthy hypertrophied kidney, in essence removal of more than
50% of functioning renal mass, stimulated rapid and dramatic
regeneration in the remnant atrophic kidney, with high levels of
renal hyperplasia, and redifferentiation in the tubular epithelium.
The present study utilizes this model of renal regeneration in
which inflammatory involvement is minimal, to give a temporal
and spatial comparison of clusterin expression in processes of
tissue remodeling that include cell proliferation, redifferentiation
of tubular epithelium and presence of apoptosis.
Methods
Animals and experimental times
Male Sprague-Dawley rats (230 to 270 g) were used. All surgical
procedures were carried out under anaesthesia (pentobarbitone
sodium, Nembutal, 50 mg/kg, i.p.), using standard guidelines for
the care and use of animals for experimental purposes. The
surgical procedures were well-tolerated and reproducible. Three
treated and two control animals per experimental time point were
studied. Tissue was collected at 0, 4, 8, 24 hours and 2, 3, 5, 7 and
14 days after operation, after the animals were given a lethal
overdose of Nembutal.
Renal regeneration
Regeneration was initiated in unilateral non-infarctive atrophic
kidneys by removal of the contralateral hypertrophied kidney. To
induce unilateral renal atrophy, experimental renal artery stenosis
of the left kidney was completed by sliding over the artery a small
surgical clip (Ethicon Ligaclip LC100) with a set gap (0.123 mm)
between its jaws. The flank incision was then closed with silk
sutures and Michel clips. Renal atrophy was allowed to develop
and stabilize over a three week period. At this stage (Time 0), the
opposite (right) kidney was surgically removed after ligation of
renal vessels and ureter. Renal regeneration was rapid and very
dramatic in the remnant kidney. The ligaclip was not removed at
time of contralateral nephrectomy because the original study [36]
had found little difference in the regenerative capacity of the
remnant kidney whether or not the clip was removed. All control
animals were sham-operated (anaesthesia, skin incision, handling
of the organ but no clip at initiation of atrophy, unilateral right
nephrectomy at time of initiation of regeneration, suturing of the
skin wound). Compensatory regrowth of the remnant kidneys of
control animals also occurred.
Tissue collection
Tissue was collected from each kidney for several different
analyses. Kidneys were bisected transversely: half was used for
extraction of total RNA and Northern hybridization; 1 to 2 mm
slices of the remaining half were fixed for in situ hybridization
studies and for immunohistochemistry. The tissue collected for
extraction of RNA was snap frozen in liquid nitrogen, and then
stored at —80°C. Tissue fixation processes for in situ hybridization
and immunolocalization studies allowed a balance between reten-
tion of morphology and retention of RNA's and immunoreactiv-
ity. Although short term (5 mm) perfusion fixation produces the
best results for morphology, this procedure could not be utilized
where RNA extraction from tissue homogenates was to be used
from part of the same kidney, for parallel whole tissue and
intrarenal localization studies. For in situ RNA analyses, phos-
phate buffered and filtered 4% paraformaldehyde, pH 7.4, was
used at 4°C to fix tissue slices overnight, followed by storage in
70% ethanol at 4°C. Other tissue slices for immunohistochemistry
were fixed for 24 hours in 10% phosphate buffered formalin,
followed by storage in 7.5% sucrose in phosphate buffered saline
at 4°C. Tissues were prepared routinely after these fixation
procedures for histological analysis. Some tissue was fixed for
electron microscopy. Small blocks (4 X 1 X 1 mm) of selected
zones of renal slices were fixed in cold Karnovsky's fixative [33],
post-fixed in 1% aqueous osmium tetroxide, stained en bloc with
5% saturated aqueous uranium nitrate, and embedded, sectioned,
and stained using routine techniques. Sections were viewed and
photographed using a Jeol JEM 1200 electron microscope.
Northern hybridization analysis
Total RNA was extracted by a guanadinium isothiocyanate-
cesium chloride method. Expression of clusterin mRNA tran-
scripts was determined by Northern blot analysis, using routine
procedures. Twenty micrograms total RNA, estimated using A280
spectrophotometric readings, was electrophoresed at 70 V in
denaturing agarose gels, then transferred and fixed to Hybond N+
membrane (Amersham) according to the manufacturer's instruc-
tions. An RNA ladder (Promega) was used in the gel and
photographed after ethidium bromide staining and UV-light
visualization, for the estimations of molecular weights. Ethidium
bromide staining of gels was also used to assess loading levels of
RNA in each lane. Northern blots were hybridized sequentially
with a 32P-labeled probe for clusterin (TRPM-2, pG2l-04) [1],
and -actin or glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) for loading controls. Blots were exposed to Kodak
XAR film for autoradiography, and mRNA levels measured by
scanning densitometry (LKB UltraScan). Using the methods of
Thompson and colleagues [37], clusterin expression levels were
then estimated as a proportion of the intensity of the hybridization
signal for the loading control. The means of these ratios were
expressed as a percent of the maximal clusterin level obtained.
In situ hybridization analysis
Paraffin-embedded sections were cut at 4 j.m thickness onto
Vectabond-coated anti-RNAase-treated slides. Methods for in
situ hybridization techniques are detailed elsewhere [1]. Essen-
tially, de-waxed sections were rehydrated, and pre-treated with
proteinase to better expose the RNA targets. Sections were
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pared from the plasmid vector (pGEM vector, Promega) contain-
ing cDNA homologous to clusterin (TRPM-2, pG2l-04) inserted
between SP6 and T7 RNA polymerase promoter sites, and cut for
sense and antisense. After hybridization, slides were treated with
RNAase (Sigma) to remove unhybridized probe, taken through a
series of washes, dehydrated and then dipped in Kodak NTB-2
photographic emulsion and exposed at 4°C for various periods of
time for best labeling. Slides were developed with Kodak D19
developer and stained with haematoxylin and eosin for viewing
and photography using light and dark field microscopy.
PCNA immunolocalization
The PC1O antibody (Oncogene Sciences) to PCNA was used for
immunohistochemistry. Deparaffinized sections were rehydrated,
and the endogenous tissue enzyme activity inhibited by incubating
all sections with methanol containing 0.3% hydrogen peroxidase.
Sections were pretreated with 0.4 N HCI for five minutes at 37°C,
incubated with normal serum, then with PCNA primary antibody
(diluted 1:20) or a non-immune serum as a control. Sections were
exposed to secondary antibody IgG, then incubated with peroxidase-
anti-peroxidase complex. The bound peroxidase activity was visual-
ized with diaminobenzidine tetrahydrochionde (DAB). PCNA ex-
pression and DNA synthesis are reported to have a close association
[38], a result corroborated by us in a separate comparative study of
cell proliferation in rat renal tissue using PCNA or 3H-thymidine
uptake (GG, unreported data). Mitotic figures identified in histolog-
ical sections were used as a double check for levels of cell prolifer-
ation measured using immunolocalization of PCNA. Proliferating
cells (PCNA-Iabeled cells per high power (X40) microscopic
field) were counted in 10 fields per tissue section and analyzed
using statistical methods. Area of high power field was 0.19 mm2.
Fig. 1. A. Atrophic kidney after three weeks of mild ischemia, opposite its
hypertrophied counterpart. The atrophic kidney (right) is pale, finely
granular, and has maintained its reniform shape. No infarcts are seen.
X2.6. B. Histology from atrophic kidney prior to regenerative stimulus.
Nephron segments lack differentiation, atrophic tubules (arrows) may be
dilated or collapsed, interstitial tissue is expanded, and normal glomeruli
(G) are seen. Foci of hypertrophied, but otherwise normal, tubules are
also found. Apoptosis and mitosis were seen infrequently. X210.
equilibrated in prehybridization buffer, then saturated with pre-
hybridization buffer under sterile plastic squares for four hours at
50°C. After prehybridization, sections were treated with hybrid-
ization buffer containing 35S-labeled clusterin riboprobes pre-
Counts of apoptosis
Apoptosis was counted in 10 high power (X40) fields from
histological sections of control and treated animals, using criteria
defined previously [33, 36, 39—41]. Only cells with morphological
features of apoptosis were counted: shrunken, eosinophilic cells
with typically condensed, marginated chromatin in their nucleus
were given single counts. Discrete apoptotic bodies comprising a
large dense nuclear fragment surrounded by a narrow cytoplasmic
rim, if found singly, were given a single count; clusters of small
apoptotic bodies were also given a single count, and any doubtful
cells were disregarded. The apoptotic process of condensation and
budding is very rapid, and counts of apoptosis performed in the
manner described may be regarded as an underestimation of true
numbers. In situ end labeling using the Klenow fragment of DNA
polymerase, digoxigenin labeled UTP, and methods detailed else-
where [42] showed labeling of morphologically identifiable apoptotic
cells, but also appeared to label some necrotic cells. Data collected in
other experiments (GG) have shown the labeling over mitotic cells,
which also have transient DNA strand breaks. Thus, results from this
method are not included. Selected tissue fixed for electron micros-
copy was used to confirm ultrastructurally that the histological
characteristics that were being quantified did represent apoptosis.
Results
Appearance of atrophic kidneys immediately prior to contralateral
nephrectomy
Figure 1A shows the macroscopic appearance of a non-infarc-
tive atrophic kidney compared with the contralateral kidney.
Histology in the atrophic kidneys after three weeks of developing
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Fig. 2. Atrophic kidney two weeks after contralateral nephrectomy.
Surface of regenerated kidneys is often nodular (seen in kidney on
right), probably because of the lack of histological uniformity in the
original atrophic kidneys, allowing some areas to regenerate faster than
others. x2.8.
Fig. 3. A. Within the first 24 hours of regeneration, apoptosis (anvws) was
found in the epithelium of many atrophic tubules. x680. B and C.
Ultrastructural analysis confirmed that the pycnotic nuclear remnants
seen in A were of apoptotic origin. In B, an epithelial cell has
phagocytosed an apoptotic body (arrow) which shows compaction of
nuclear chromatin against the nuclear envelope. X8500. In C, lysosomal
degradation of an apoptotic body with several nuclear fragments
(arrows) is occurring. X 10400.
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atrophy, and at the time of contralateral nephrectomy (TO),
comprised zones of atrophic tubules, intermingled with expanded
interstitium and small foci of hypertrophied, but otherwise normal
tubular epithelium (Fig. 1B). The atrophic tubules were dediffer-
entiated, with either flattened epithelium around dilated lumina,
or collapsed tubules, with epithelium that had lost characteristics
such as brush borders in proximal tubules or villi on distal tubular
luminal borders. Lateral cell-to-cell contacts in the tubular
epithelium had also been lost in many instances. Apoptosis was
not often seen in atrophic tubules at this stage of the experiment.
A base level was found using quantitation. Glomeruli were close
together, presumably because of the intervening tubular atrophy,
but were usually healthy, with occasional glomerulosclerosis.
Some vessel abnormalities were observed, comprising intimal
thickening and reduplication of internal elastic lamina. Inflamma-
tory responses such as would be found in cases of acute tubular
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Fig. 5. A. Example of Northern blot analysis of RNA extracted from kidneys
of one or two rats at different experimental time points. Control kidneys
(Lanes 1 and 2), atrophic kidneys just prior to regenerative stimulus (TO,
Lanes 3 and 4), and kidneys after contralateral ncphrectomy (4 hr, lanes
5 and 6; 8 hr, lane 7; 24 hr, lanes 8 and 9; 48 hr, lane 10; 7 days, lane 11;
14 days, lanes 12 and 13). The 1.3 kb transcript for SGP-2 (lower panel)
was found to have greatly increased expression 4 hours after the regen-
erative stimulus, dropping to untraceable levels by 48 hours in this blot.
RNA for 3 days was degraded in this blot, and was removed for
photography, and RNA for 5 days regenerating kidney was not included in
this blot. Upper panel shows the same blot stripped and then probed with
j3-actin as an indication of loading levels. B. Diagrammatic representation
of expression on Northern blots, measured by scanning densitometry.
Graph shows means of levels of clusterin mRNA as a ratio of correspond-
ing loading control, and shown as a percent of maximal level of clusterin
expression, following the methods of Thompson et al [37].
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Fig. 4. Diagrammatic representation of the temporal changes of levels of
apoptosis (a) and cell proliferation estimated using PCNA immunolocal-
ization (U) shown in Table 1. The peak in apoptosis within the first 24
hours is not insignificant, given the rapidity of the apoptotic process. X
axis: time in days; Y axis: counts of apoptosis or PCNA per 0.19 mm2 of
tissue section (X40 objective lens).
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Fig. 6. In situ hybridization of 35S-radiolabeled riboprobes of the clusterin gene in tissue sections of 4 hour regenerating kidney. Lightfield (A) and darkfield
(B) photomicrographs show signal strongest over all cells in some tubular epithelial structures, whilst other more normal-looking tubules have only
background levels of expression. X380.
Table 1. Counts of apoptosis and PCNA-stained cells per high power
field (x40 objective, 0.19 mm2 of tissue) in tissue sections from animals
in which regeneration was induced by contralateral nephrectomy in 3
week atrophic kidneys (columns 2 and 3), or control (sham operated)
animals (columns 4 and 5)
Time
Apoptosis PCNA Apoptosis PCNA
Regeneration Shams
0 hours 0.35 0.13 0.84 0.18 0 0.3 0.21
4 hours 3.45 0.52 0.55 0.13 0.05 0.05 0.45 0.17
8 hours 2.8 0.47 0.75 0.2 0 0.5 0.17
24 hours 1.4 0.34 1.4 0.34 0.05 0.05 0.3 0.16
2 days 0.95 0.28 5.6 1.03 0.05 0.05 0.4 0.13
3 days 1.0 0.33 11.55 1.56 0 0.85 0.18
5 days 0.8 0.21 10.1 1.14 0 1.25 0.25
7 days 0.7 0.25 2.05 0.38 0.05 0.05 1.1 0.28
14 days 0.65 0.13 1.1 0.32 0 0.45 0.19
Counts are expressed as means standard deviation of mean.
necrosis were not present. No histological abnormalities were
observed in control kidneys at TO.
Macroscopic and microscopic changes after the regenerative
stimulus
On macroscopic examination of regenerating treated kidneys,
the surface of the kidneys appeared either smooth, or slightly
nodular as time of regeneration progressed (Fig. 2). Histology, on
superficial examination, appeared very similar to that seen at TO,
with increase in area of epithelium of atrophic and healthy tubules
being apparent. On examination of tissue collected during the first
24 hours, an unexpected feature found during this acute regener-
ative phase was the appearance, in the epithelium or lumina of
many atrophic (dedifferentiated) tubules, of one to several apop-
totic cells or groups of apoptotic bodies (Fig. 3A). Ultrastructural
characteristics of apoptosis were confirmed on examination of
sections prepared for electron microscopy (Fig. 3 B,C). Levels of
apoptosis (Fig. 4, Table 1) peaked during this acute phase, and
dropped after 48 hours to base levels found in the atrophic
kidneys prior to regeneration. Remodeling of the atrophic tubular
epithelium, with redevelopment of some surface characteristics of
tubular epithelial cells (redifferentiation), was observed after
several days. Histology of control (sham-operated) kidneys veri-
fied previous work [36] that showed regeneration consisted mainly
of cellular hypertrophy, with little hyperplasia and little or no
apoptosis being observed (Table 1).
Expression of clusterin after induction of regeneration
Figure 5A is an example of autoradiography from Northern
blots of total RNA extracted from kidneys collected at the set
experimental times after stimulus of regeneration, and probed
with either -actin (upper autoradiograph, loading control) or
clusterin (lower autoradiograph). Atrophic kidneys (TO) had
minimal, but traceable, expression of clusterin (lanes 3 and 4).
This may have been induced by the ongoing regressive stimulus
(experimental renal artery stenosis) causing a slow but continual
reduction in renal size, with associated tissue restructuring. In the
regenerating kidneys, clusterin expression was greatly augmented
at four hours (peak, lanes 5 and 6), and eight hours (lane 7) after
induction of the regenerative response, with expression dropping
to minimal or undetectable levels after three days. Control
(sham-operated) regenerating kidneys had no traceable expres-
sion of clusterin, confirming the work of others [2]. Autoradio-
graphs from Northern blots were evaluated by scanning laser
densitometry. Figure 5B shows levels of clusterin expression which
were estimated as a ratio of the corresponding loading control
expression, and then as a percent of the maximal level of clusterin
obtained, according to the methods of Thompson et al [37].
In situ hybridization of clusterin in histological sections
Expression was localized usually, but not exclusively, in the
dedifferentiated tubules of atrophic kidneys after stimulus of
regeneration. Light and dark field photomicrographs demonstrate
this localization (Fig. 6 A,B). Expression of clusterin was not
associated exclusively with apoptotic cells, but also with viable
(regenerating) cells (Fig. 6C). The results indicate involvement of
the gene in remodeling (redifferentiation) of the tubular epithe-
hum into histologically distinguishable nephron segments. Its final
biological function may depend on other associated proteins.
Other local areas of expression were around some blood vessel
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Fig. 6. Continued. C. In situ hybridization of clusterin mRNA in dilated
atrophic tubules, 8 hours after stimulus to regenerate. Signal is over both
apoptotic cells with dark pycnotic nuclei (arrows, visualized under the
signal), and over other apparently viable cells that may be undergoing
changes for regrowth and redifferentiation. X460.
walls. Expression was rarely found over the focal areas of tubular
hypertrophy. Sections prepared for sense and antisense hybridiza-
tion techniques had equivalent background, but only sections
prepared for antisense hybridization showed definitive localized
zones over some tubules and vessels. Sections from control
kidneys showed no hybridization above background levels, and
sections from atrophic kidneys (TO) showed minimal hybridiza-
tion, often localized over atrophic tubules near the corticomedul-
lary junction.
Cell proliferation assessed by PCNA immunolocalization
PCNA counts (Fig. 4 and Table 1) peaked at three to five days
in atrophic kidneys after stimulus to regenerate by contralateral
nephrectomy. Epithelial cells of the dedifferentiated atrophic
tubules most often demonstrated increased expression of PCNA
(Fig. 7A). Mitotic figures were observed, again mostly in the
dedifferentiated tubules, with mitotic cells being found most often
at three to five days (Fig. 7B). After unilateral nephrectomy,
control kidneys had a slight increase in PCNA expression (Table
1).
Fig. 7. A. PCNA immunolocalization in 5 day regenerating kidney tissue
sections. PCNA immunolocalization is demonstrated by the dark brown-
stained nuclei. Some examples are indicated (arrows). B. Mitotic figures
were often identified, and are seen here (arrows) in the regenerating
epithelium of renal tissue from 3-day regeneration animals. x720.
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Discussion
We have been interested in the characterization of certain
factors involved in control of renal growth, particularly compen-
satory growth after renal injury. At the clinical level, renal
regeneration is critical for the survival of patients. At the funda-
mental level, understanding cellular growth in normal and patho-
logical states has application in many processes, including cancer
development. Several papers had recorded increased levels of
clusterin in renal diseases in which regrowth is an integral part [2,
3, 5—9]. Similarly, increased clusterin expression has been ob-
served in examples of renal oncogenesis [15, 161. Hence, we
decided to use a model of renal regeneration in which the
pathology had been previously described [36] to carry out tempo-
ral and spatial analysis of clusterin expression in association with
known regenerative changes that included proliferation, tissue
redifferentiation and remodeling, with minimal apoptosis esti-
mated at the times of analysis in the previous study. In the model,
unilateral renal artery stenosis was used to induce renal atrophy,
followed by contralateral nephrectomy to stimulate regeneration
in the atrophic kidney. At time of induction of regeneration, there
was minimal involvement of immune system, apoptosis was seen
infrequently, and many atrophic tubules were dedifferentiated.
Stimulation of regrowth initiated high levels of hyperplasia and
redifferentiation of tubular epithelium.
After contralateral nephrectomy in renal artery stenosis-treated
animals, the cell population in the dedifferentiated atrophic
tubules underwent rapid, detectable change. An unexpected in-
crease in apoptosis was apparent morphologically in the first 24
hours, followed at later times by cell proliferation and tubular
re-differentiation. Increased clusterin mRNA levels correlated
with the peak in apoptosis, rather than the peak in cell prolifer-
ation or morphologically-identifiable redifferentiation in tubular
epithelium. These results contrast with post-natal nephrogenesis
in rats, where high levels of clusterin expression occur at a time
when all three factors, proliferation, apoptosis, and differentiation
to mature nephrons, are functioning. This comparison is made
with the results from two other published studies [4, 40], and
warrants a more descriptive integrated study. In the present study,
clusterin expression was usually localized over the epithelial cells
of dedifferentiated tubules which included apoptotic cells as well
as apparently viable cells. These cells may have been undergoing
gene alterations related to proliferation or redifferentiation which
were observed at later times. Tubular cell hypertrophy also
occurred in response to the regenerative stimulus, but mostly in
foci of non-atrophic tubules at later times in the regenerative
process. Clusterin was rarely localized over these cells.
Although there are many reports of a close association between
clusterin expression and apoptosis, there have also been reports
detailing a lack of correlation, and some that indicate a link
between clusterin expression and the surviving cells, rather than
the apoptotic cells, in regressing tissues [21, 31, 32]. The studies by
French and colleagues [21, 32] appear to be the most compelling
with regards lack of an association between clusterin and apop-
tosis. The link that is proposed between clusterin and morpholog-
ically normal and surviving cells, however, is not well substanti-
ated. In the more recent of the publications by French and
colleagues [32], the cells are shown only by low power light
microscopy that does not provide differentiation of nuclear and
cytoplasmic criteria usually needed to define morphologic normal-
ity. All of the photomicrographs of apoptosis, lacking clusterin
expression, show the process in its latter stages, as small apoptotic
bodies. What happens to expression of clusterin over cells in early
(nuclear) apoptosis prior to cell shrinkage and blebbing is not
shown. The study was carried out using in vitro experiments, and
their results contrast with those from the present in vivo work
which demonstrates clusterin mRNA increased under a regener-
ative, rather than regressive, stimulus. While it is found over
apparently viable cells, it is also found over apoptotic cells. In this
instance, its role would appear to relate more to tissue restruc-
turing. Such a process involves many factors (redifferentiation,
proliferation, apoptosis, growth), and ultrastructural gene local-
ization studies may now be needed to define any exact clusterin-
related cellular function.
The rapid response seen in the atrophic tubules in the first 24
hours was dramatic, and may be explained in the following way. It
was in these structures that apoptosis was known to contribute to
the pathogenesis of renal atrophy, prior to regeneration [36]. A
gene association (c-fos, c-myc, HSP7O) has been found to precede
both mitosis and apoptosis in a similar study of renal atrophy [2].
Thus, the atrophic tubules may have been "primed" for rapid
response to the regenerative stimulus. The transient increase in
apoptotic cell death was one of the novel findings of the present
study. This rapid and unusual response to a regenerative, rather
than death, stimulus needs careful consideration. Tubular atrophy
can be found as part of many human renal diseases, including
hydronephrosis, renal artery stenosis, radiation damage, analgesic
nephropathy, and hypertensive and glomerular diseases. Some of
these diseases are linked with renal oncogenesis. The unusual
peak in apoptosis on induction of regeneration may be necessary
for removal of effete or damaged cells, and aberrant expression of
genes controlling such a process may be important, for example,
in development of renal cancers.
The balance, or more correctly the imbalance, between apop-
tosis and mitosis has proven to be an important factor in tumour
progression [41—44], and the correlation between increased clus-
term expression and apoptosis warrants further comment in this
context. Several recent papers provide a link between expression
of the gene and tumour development in different tissues and
organs including the kidney. One report [16] records clusterin
(gp8O) levels three times higher in malignant tissue than in
adjacent normal renal tissue, in human renal clear cell carcino-
mas. Three possible causes are debated: increased cell mass in the
tumour and therefore increased cell to cell interactions; trans-
formed cells having higher survival rates; and/or increased apop-
tosis found to occur in untreated tumours. Likewise, clusterin
(SGP-2) was specifically expressed in the malignant epithelium
after N-nitroso-N-methyl urea induction of tumors of the prostate
and seminal vesicles [22]. Other papers have recorded that
clusterin expression increased in rodent and human breast tumors
soon after hormone withdrawal and persisted during all stages of
apoptosis [17, 19], although one of these reports [17] described
clusterin (TRPM-2) in only 17% of breast cancers. Clusterin
expression is increased during apoptosis-mediated regression of
hormone-related tumors [18]. It is also highly expressed in
early-stage tumors of the rat prostate [20]. Whether its role is a
protective one for tumor development, rather than a mediator of
the process of apoptotic cell deletion [17, 18], is not at all clear. Its
link with apoptosis has yet to be disproved. Nonetheless, its
expression appears to be an important indicator of tumorigenesis
in these instances.
Dvergsten and co-workers [15] reviewed expression of clusterin
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in a wide range of human renal diseases. It was found in all cases
of transplant rejection, seven of fifteen cases of renal tumors, all
cases of cystic disease, renal hypoplasia and dysplasia. Renal cell
cancers and polycystic disease share many of the morphological
characteristics found in the pathology of renal tissue studied in the
present model: abnormally dilated tubules, dedifferentiated epi-
thelium, loss of cell-to-cell contact and cell-to-basement mem-
brane contact prior to simulation to regrowth, and apoptosis,
hyperplasia, and redifferentiation in the growth-stimulated kid-
neys. However, the exact role of clusterin in the process is still not
defined, and it appears unlikely that localization studies similar to
those used in the present study will do much more to elucidate its
role. More sophisticated in situ localization studies may prove to
be informative, with each instance of altered clusterin expression
analyzed against the stimulus for change.
In summary, the results demonstrate increased clusterin mRNA
in response to a regenerative stimulus, concurrent with increased
but unexpected apoptosis, and prior to morphologically distinct
tissue regrowth that involved renal tubular hyperplasia and some
hypertrophy. Expression was usually localized over dedifferenti-
ated tubules with both apoptotic and surviving cells in the
epithelium. Tissue remodeling, along with redifferentiation of
tubular epithelial cells, occurred during and after the peak in
clusterin expression. Although there are several recent publica-
tions that discount a direct link between apoptosis and clusterin
expression, future studies may show that additional proteins act
along with clusterin, explaining its diverse spectrum of biological
effects that may include apoptosis. Apoptosis is critical for main-
tenance of appropriate cell numbers and for tissue organization.
The rapid and unexpected induction of apoptosis in response to a
regenerative stimulus, rather than a stimulus that inhibits growth
or causes tissue atrophy, indicates that a population of effete or
damaged cells may need to be deleted before stimulation of the
hyperplastic response for renal regrowth. Further study of these
cells may yield new information about early changes in renal
oncogenesis, as well as information about the molecular events
involved in the extremes between cell latency and active growth
processes in the kidney.
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